AAVXF
Price
$11.05
Change
-$0.00 (-0.00%)
Updated
Jul 30 closing price
IMNN
Price
$0.75
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
132 days until earnings call
Ad is loading...

AAVXF vs IMNN

Header iconAAVXF vs IMNN Comparison
Open Charts AAVXF vs IMNNBanner chart's image
Abivax SA
Price$11.05
Change-$0.00 (-0.00%)
Volume$1K
CapitalizationN/A
Imunon
Price$0.75
Change-$0.00 (-0.00%)
Volume$165.64K
CapitalizationN/A
AAVXF vs IMNN Comparison Chart
Loading...
IMNN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AAVXF vs. IMNN commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a Hold and IMNN is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (AAVXF: $11.05 vs. IMNN: $0.75)
Brand notoriety: AAVXF and IMNN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 100% vs. IMNN: 78%
Market capitalization -- AAVXF: $634.74M vs. IMNN: $10.85M
AAVXF [@Biotechnology] is valued at $634.74M. IMNN’s [@Biotechnology] market capitalization is $10.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 0 FA rating(s) are green whileIMNN’s FA Score has 0 green FA rating(s).

  • AAVXF’s FA Score: 0 green, 5 red.
  • IMNN’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNN is a better buy in the long-term than AAVXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNN’s TA Score shows that 3 TA indicator(s) are bullish.

  • IMNN’s TA Score: 3 bullish, 4 bearish.

Price Growth

AAVXF (@Biotechnology) experienced а 0.00% price change this week, while IMNN (@Biotechnology) price change was -8.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

IMNN is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAVXF($635M) has a higher market cap than IMNN($10.8M). IMNN YTD gains are higher at: 10.000 vs. AAVXF (8.440).
AAVXFIMNNAAVXF / IMNN
Capitalization635M10.8M5,880%
EBITDAN/AN/A-
Gain YTD8.44010.00084%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A1.51M-
FUNDAMENTALS RATINGS
AAVXF vs IMNN: Fundamental Ratings
AAVXF
IMNN
OUTLOOK RATING
1..100
4758
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
88100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
7390
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMNN's Valuation (50) in the Medical Specialties industry is in the same range as AAVXF (58) in the null industry. This means that IMNN’s stock grew similarly to AAVXF’s over the last 12 months.

AAVXF's Profit vs Risk Rating (88) in the null industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that AAVXF’s stock grew similarly to IMNN’s over the last 12 months.

AAVXF's SMR Rating (98) in the null industry is in the same range as IMNN (98) in the Medical Specialties industry. This means that AAVXF’s stock grew similarly to IMNN’s over the last 12 months.

AAVXF's Price Growth Rating (73) in the null industry is in the same range as IMNN (90) in the Medical Specialties industry. This means that AAVXF’s stock grew similarly to IMNN’s over the last 12 months.

AAVXF's P/E Growth Rating (100) in the null industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that AAVXF’s stock grew similarly to IMNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMNN
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
IMNN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

AAVXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAVXF has been loosely correlated with BPMUF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AAVXF jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAVXF
1D Price
Change %
AAVXF100%
N/A
BPMUF - AAVXF
47%
Loosely correlated
N/A
CSCI - AAVXF
46%
Loosely correlated
-3.40%
SRPT - AAVXF
45%
Loosely correlated
-3.00%
ABCZF - AAVXF
31%
Poorly correlated
N/A
IMNN - AAVXF
28%
Poorly correlated
+0.17%
More

IMNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNN has been loosely correlated with VANI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNN jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNN
1D Price
Change %
IMNN100%
+0.17%
VANI - IMNN
35%
Loosely correlated
+3.60%
STOK - IMNN
29%
Poorly correlated
+0.14%
DTIL - IMNN
28%
Poorly correlated
-4.70%
QTTB - IMNN
28%
Poorly correlated
-10.32%
AAVXF - IMNN
28%
Poorly correlated
N/A
More